483 Boehringer Ingelheim Pharmaceuticals Jul 2017

483 Boehringer Ingelheim Pharmaceuticals Jul 2017

$119 - Not in Stock

FDA investigators audited the Boehringer Ingelheim Pharmaceuticals - Danbury, CT, United States facility and issued inspectional observations (via FDA 483) on 28 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Jul 2017
  • Location: Danbury, United States
  • FEI: 1219205
Order